𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Use of the HCV subgenomic replicon for the selection and characterization of variants with reduced susceptibility to interferon alpha-2A

✍ Scribed by C. Laxton; E. Hobbs; S. Fletcher; J.A Symons; R. Bartenschlager; M. Graves; R. Devos; I. Najera


Book ID
119526874
Publisher
Elsevier Science
Year
2001
Tongue
English
Weight
166 KB
Volume
34
Category
Article
ISSN
0168-8278

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Variants in interferon-alpha pathway gen
✍ Tania Mara Welzel; Timothy R. Morgan; Herbert L. Bonkovsky; Deepa Naishadham; Ru πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 270 KB πŸ‘ 2 views

Combination treatment with pegylated-interferon-alpha (PEG IFN-␣) and ribavirin, the current recommended therapy for chronic hepatitis C virus (HCV) infection, results in a sustained virological response (SVR) in only about half of patients. Because genes involved in the interferon-alpha pathway may

Usefulness of simple assays for serum co
✍ Toshio Suzuki; Eiji Tanaka; Akihiro Matsumoto; Akihiko Urushihara; Takeshi Sodey πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 781 KB

## Abstract The use of two new assays was evaluated for predicting the response to interferon (IFN) therapy in patients with chronic hepatitis C. The genotype of hepatitis C virus (HCV) was establishe by an enzyme‐linked immunosorbent assay based on genotype‐specific recombinant peptides of the NS4